Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Obes Surg. 2011 Jul;21(7):930-4. doi: 10.1007/s11695-010-0295-8.

Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations.

Author information

  • 1Department of Pediatrics, Division of Endocrinology, University of California San Francisco, San Francisco, CA 94143, USA.

Abstract

BACKGROUND:

Heterozygous mutations in melanocortin-4 receptor (MC4R) are the most frequent genetic cause of obesity. Bariatric surgery is a successful treatment for severe obesity. The mechanisms of weight loss after bariatric surgery are not well understood.

METHODS:

Ninety-two patients who had Roux-en-Y gastric bypass (RYGB) surgery were screened for MC4R mutations. We compared percent excess weight loss (%EWL) in the four MC4R mutation carriers with that of two control groups: 8 matched controls and with the remaining 80 patients who underwent RYGB.

RESULTS:

Four patients were heterozygous for functionally significant MC4R mutations. In patients with MC4R mutations, the %EWL after RYGB (66% EWL) was not significantly different compared to matched controls (70% EWL) and non-matched controls (60% EWL) after 1 year of follow-up.

CONCLUSIONS:

This study suggests that patients with heterozygous MC4R mutations also benefit from RYGB and that weight loss may be independent of the presence of such mutations.

PMID:
20957447
[PubMed - indexed for MEDLINE]
PMCID:
PMC3119798
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk